1. Home
  2. REFR vs ICCM Comparison

REFR vs ICCM Comparison

Compare REFR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$1.62

Market Cap

54.8M

Sector

Miscellaneous

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.69

Market Cap

45.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFR
ICCM
Founded
1965
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
54.8M
45.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REFR
ICCM
Price
$1.62
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
60.0K
403.0K
Earning Date
11-06-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,227,276.00
$2,975,000.00
Revenue This Year
N/A
$13.67
Revenue Next Year
N/A
$38.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$0.59
52 Week High
$2.70
$1.66

Technical Indicators

Market Signals
Indicator
REFR
ICCM
Relative Strength Index (RSI) 44.04 41.99
Support Level $1.85 $0.67
Resistance Level $2.10 $0.72
Average True Range (ATR) 0.17 0.05
MACD -0.03 0.01
Stochastic Oscillator 17.24 62.50

Price Performance

Historical Comparison
REFR
ICCM

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: